![](https://investorshub.advfn.com/uicon/47187.png?cb=1465055851)
Friday, December 02, 2011 11:21:16 PM
Dr. Anil R. Diwan, Ph.D., has been Chairman of the Board and President of Nanoviricide, Inc. since June 1, 2005. Dr. Diwan has been the Chief Executive Officer of All Excel, Inc. since 1995 and TheraCour Pharma, Inc. since 2004. He is the original inventor of the technologies licensed to NanoViricides Inc., as well as the TheraCour polymeric micelle technologies and products based on them. Since 1992, he has researched and developed TheraCour nanomaterials. Dr. Diwan has extensive product development experience while raising financing from collaborations, SBIR grants, other revenues. He has extensive experience in a number of bio-pharmaceutical, biosciences, and biomedical fields and technologies that leads to his novel, integrative approach in solving problems with low costs, high innovation, and world-leading feature sets. Dr. Diwan is the inventor, developer, and principal investor of TheraCour technologies. The nanomaterials based on these technologies form the basis of nanoviricides drugs.
At any rate not sure why you came to my board and called me out about this stock. The info is old and research was for finding the driving forces behind the company. Any time I see a VC dumping 2 $5 million funding deals into a company with a falling price, I feel they are an arm of that company. Thats why I speculated the shell thing.
I'd be more concerned about the company not up listing when they were above a buck or the owners selling, then some old post guess about a new funding partner.
PS, Diwan stopped selling Oct 17,right when the small comeback happened. Wonder who's selling it now? TheraCor's 33 mil or this Eugene Seymour, who holds 6 mil and sold 2.5 mil Nov 2010?
The thing is these few big money players are behind the company and if their letting the price dive, there is a reason. Damn sure they have enough cash to buy the price back with only 250k avereage daily volume if they wanted.
Good luck with NNVC
Welcome to my mind!
Success to all
IHUB http://investorshub.com/boards/board.asp?board_id=3972
http://youtube.com/lowtrade
Incumbents: Fire them all!!
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM